Professional Documents
Culture Documents
2014
The Role of Decidual Natural Killer Cells, Interleukin-15 and Interferon- in Placental
1
2
4
5
USA
Cell and Developmental Biology, Weill Cornell Medical College, New York, NY 10021, USA
8
9
10
11
12
13
14
15
16
17
18
19
Cornell University
20
21
e-mail: robin.davisson@cornell.edu
22
Phone: 607-253-3598
23
Fax: 607-253-3378
24
Abstract
25
26
and is a leading cause of maternal and perinatal morbidity/mortality (13). The primary treatment
27
for preeclampsia still is delivery of the fetus and placenta. The underlying mechanisms remain
28
29
time of implantation (14). Here, we review evidence for dysregulation of decidual Natural Killer
30
(dNK) cells, which secrete important angiogenic factors during decidualization, as a contributing
31
factor in preeclampsia.
32
33
In rodents and humans, implantation is the first coordinated encounter between mother
34
and baby (7). The process of decidualization is defined as the differentiation of uterine stromal
35
cells into epithelial-like decidual tissue, beginning during the periimplantation period at
36
embryonic day (e) 4.5 in mice (7). This transitory process is characterized by significant vascular
37
remodeling of the uterus (e5.5-7.5) to ensure proper placental blood flow (7). The decidua also
38
39
40
cells, the predominant immune cell at the maternal-fetal interface (4, 9, 10). Activation of dNK
41
42
decidualization, lack mature dNK cells and, interestingly, produce low-birth-weight pups (3).
43
Exogenous IL-15 administration in these mice restores dNK cell populations, thus confirming its
44
importance in dNK cell maturation. In mice, mature dNK cells are recognized histologically by
45
their lymphoid shape and cytoplasmic granules that react with Dolichos biflorus agglutinin
46
(DBA) (5). DBA+ cells have been identified as early as e5.5 in the decidua (12). They continue
47
to proliferate and accumulate at the base of the placenta, obtaining peak numbers at mid-
48
gestation (~e12.5) and declining thereafter (5). Mature dNK cells maintain decidual integrity and
49
produce factors that directly modify decidual vessels (10). Upon stimulation by IL-15, dNK cells
50
begin secreting key angiogenic factors, including interferon- (IFN-) (12). In mice, IFN-
51
provides the signals that transiently change spiral arteries from constricted to dilated high-
52
capacitance vessels necessary for adequate placental perfusion (4). Endometrial IFN- expression
53
mirrors dNK cell localization in the uterus (12). This expression profile was not observed in a
54
mouse strain (tg26; NK-T-B+) having much reduced levels (only 1%) of normal dNK cell
55
numbers (1). IFN- is also thought to promote senescent decline of dNK cells after mid-gestation
56
(5). Implantation sites from Ifng null mice exhibit excessive numbers of incompletely
57
differentiated dNK cells, widespread decidual necrosis, inappropriate spiral artery modifications
58
(12) and significant fetal loss (1). Treatment of alymphoid mice with recombinant IFN- results
59
in normal decidual and arterial morphology (12). Therefore, the production of IFN- by dNK
60
cells is critical for gestational changes in the decidua and uterine vasculature.
61
Increased decidual IL-15 expression has been linked to recurrent miscarriage in women,
62
suggesting impaired implantation and vascularization of the placenta (15). Other reports have
63
64
compared to healthy controls, where IL-15 levels were proportional to severity of disease
65
presentation (11). These findings provide evidence that IL-15 may be involved in poor
66
pregnancy outcomes. IFN- may also play a role in preeclampsia, since its reported to be
67
elevated in plasma, circulating leukocytes, and decidua from patients with preeclampsia (12).
68
There is conflicting evidence regarding the significance of dNK cells in pregnancy outcomes.
69
Some reports state that dNK cells are increased in preeclampsia, albeit with an altered phenotype
70
(2), while others show dNK cells are decreased in preeclamptic placental samples (17).
71
Interestingly, others propose that dNK cell function, rather than number, may be altered in
72
preeclampsia (16).
73
Because dNK cells are critical for uterine angiogenesis and spiral artery remodeling,
74
gestational processes that are often pathologic in preeclamptic pregnancies, we asked whether
75
dNK cell activation and function were dysregulated prior to placenta formation in our model of
76
preeclampsia, BPH/5. These mice spontaneously develop the maternal signs of preeclampsia,
77
including hypertension and proteinuria, as well as similar placental defects observed in human
78
preeclamptic placentae such as inadequate remodeling of spiral arteries (6, 8). We found dNK
79
cell mRNA expression in BPH/5 implantation sites was similar to C57Bl/6 controls at e4.5, but
80
dramatically reduced at e5.5. This finding was confirmed by a marked decrease in mature dNK
81
cell numbers at e5.5 in BPH/5 implantation sites as measured by flow cytometry and
82
immunohistochemistry for DBA+ cells. Further, IL-15 mRNA was significantly increased in
83
BPH/5 implantation sites compared to controls at e4.5 and e5.5, when decidualization first
84
begins, while other pro-inflammatory cytokines were unchanged. One hypothesis is that high
85
levels of IL-15 may be induced to help promote more dNK cell activation in BPH/5; however,
86
this is currently under investigation. We speculate that an early increase in IFN- mRNA in e4.5
87
BPH/5 implantation sites contributes to dNK cell loss. These findings support the hypothesis that
88
periimplantation events may lead to early impaired uterine angiogenesis and placental
89
90
91
Both dNK cell activation by IL-15, and dNK secretion of IFN- are crucial for placental
92
development. Interestingly, BPH/5 mice show elevations in IL-15 and IFN- mRNA as well as a
93
dramatic reduction in mature dNK cells. Other mouse models lacking dNK cells, IL-15, or IFN-
94
have significant placental and/or fetal abnormalities. Furthermore, women with pregnancy-
95
related disorders also show dysregulation in IL-15, IFN-, and dNK cells. Therefore,
96
understanding the significance of dNK cells and related cytokines in preeclampsia and other
97
98
models such as the BPH/5 offer critical tools for investigating this at the earliest stages of
99
pregnancy.
Mouse
100
101
GRANTS
102
103
REFERENCES
104
105
106
107
Aberrant uterine natural killer (NK)-cell expression and altered placental and serum levels of the
108
109
292-301, 2006.
110
3. Barber EM and Pollard JW. The uterine NK cell population requires IL-15 but these cells
111
are not required for pregnancy nor the resolution of a Listeria monocytogenes infection.
112
113
4. Burke SD, Barrette VF, Gravel J, Carter AL, Hatta K, Zhang J, Chen Z, Leno-Duran E,
114
Bianco J, Leonard S, Murrant C, Adams MA and Croy BA. Uterine NK cells, spiral artery
115
116
117
5. Croy BA, Chantakru S, Esadeg S, Ashkar AA and Wei Q. Decidual natural killer cells: key
118
119
6. Davisson RL, Hoffmann DS, Butz GM, Aldape G, Schlager G, Merrill DC, Sethi S, Weiss
120
121
122
7. Dey SK, Lim H, Das SK, Reese J, Paria BC, Daikoku T and Wang H. Molecular cues to
123
124
8. Dokras A, Hoffmann DS, Eastvold JS, Kienzle MF, Gruman LM, Kirby PA, Weiss RM
125
and Davisson RL. Severe feto-placental abnormalities precede the onset of hypertension and
126
127
128
2013.
129
10. Herington JL and Bany BM. Effect of the conceptus on uterine natural killer cell numbers
130
and function in the mouse uterus during decidualization. Biol.Reprod. 76: 4: 579-588, 2007.
131
11. Hu W, Wang H, Wang Z, Huang H and Dong M. Elevated serum levels of interleukin-15
132
133
12. Murphy SP, Tayade C, Ashkar AA, Hatta K, Zhang J and Croy BA. Interferon gamma
134
135
13. Soto E, Romero R, Kusanovic JP, Ogge G, Hussein Y, Yeo L, Hassan SS, Kim CJ and
136
137
anti-angiogenic factors in patients with and without placental lesions consistent with maternal
138
139
14. Torry DS, Hinrichs M and Torry RJ. Determinants of Placental Vascularity. 51: 4: 257-
140
268, 2004.
141
142
143
144
16. Wallace AE, Host AJ, Whitley GS and Cartwright JE. Decidual natural killer cell
145
146
147
17. Williams PJ, Bulmer JN, Searle RF, Innes BA and Robson SC. Altered decidual
148
leucocyte populations in the placental bed in pre-eclampsia and foetal growth restriction: a
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163